| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Coeptis Therapeutics Holdings, Inc. | VP Compliance and Secy | Common Stock | 64,031 | $920,765 | $14.38 | 11 Feb 2026 | Direct |
| Coeptis Therapeutics Holdings, Inc. | VP Compliance and Secy | Non-Qualified Stock Options (right to buy) | 13,500 | 04 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| COEP | Coeptis Therapeutics Holdings, Inc. | 11 Feb 2026 | 2 | +$10,560 | 4 | VP Compliance and Secy | 13 Feb 2026, 17:00 |
| COEP | Coeptis Therapeutics Holdings, Inc. | 04 Mar 2025 | 1 | $0 | 4 | VP Compliance and Secy | 06 Mar 2025, 17:28 |
| COEP | Coeptis Therapeutics Holdings, Inc. | 27 Jan 2023 | 1 | $0 | 4 | CFO and Secretary, Director | 31 Jan 2023, 10:05 |
| COEP | Coeptis Therapeutics Holdings, Inc. | 28 Oct 2022 | 0 | $0 | 3 | CFO and Secretary | 07 Nov 2022, 13:01 |